From: The role of the fat mass and obesity associated gene (FTO) in breast cancer risk
 | Additive effects | Dominance effects | ||||
---|---|---|---|---|---|---|
 | aModel 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 |
rs9939609 | 3.515* (1.41-8.708) | 3.281* (1.32-8.16) | 3.719* (1.43-9.68) | 0.515* (0.31-0.84) | 0.531* (0.32-0.87) | 0.506* (0.30-0.88) |
rs1477196 | 31.589** (10.27-97.11) | 27.551** (8.98-84.52) | 30.111** (9.65-94.80) | 0.509* (0.31-0.83) | 0.515* (0.32-0.84) | 0.458* (0.27-0.77) |
rs7206790 | 1.865* (1.11-3.13) | 1.802* (1.07-3.03) | 1.888* (1.08-3.29) | 1.074 (0.71-1.63) | 1.094 (0.72-1.66) | 1.088 (0.68-1.65) |
rs8047395 | 0.247* (0.10-0.61) | 0.262* (0.11-0.64) | 0.281* (0.12-0.68) | 0.822 (0.52-1.30) | 0.841 (0.53-1.33) | 0.847 (0.52-1.38) |